Effects of CS-866, an angiotensin II receptor antagonist, in 5/6 nephrectomized spontaneously hypertensive rats

Japanese Journal of Nephrology

Volumn 43, Issue 7, 2001, Pages 580-588

  Xu, Hong Lan ^a   Yoshida, Kazunori ^a   Wu, Xue Min ^a   Kohzuki, Masahiro ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic renal failure; CS 866; Spontaneously hypertensive rat; Temocapril

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; OLMESARTAN; TEMOCAPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; AORTA; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CORRELATION FUNCTION; DECAPITATION; DOSE RESPONSE; GLOMERULOSCLEROSIS; HEART; KIDNEY; NEPHRECTOMY; NONHUMAN; ORGAN WEIGHT; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; HYPERTENSION; IMIDAZOLES; KIDNEY FAILURE, CHRONIC; MALE; NEPHRECTOMY; RATS; RATS, INBRED SHR; RECEPTORS, ANGIOTENSIN; TETRAZOLES; THIAZEPINES;

EID: 0034754419     PISSN: 03852385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Ichiki T, Labosky PA, Shiota C, Okuyama S, Imagawa Y, Fogo A, Niimura F, Ichikawa I, Hogan BL, Inagami T. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 1995 ; 377 : 748-50.
2. Anderson S, Meyer TW, Rennke HG, Brenner BM. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 1985 ; 76 : 612-9.
3. Keane WF, Anderson S, Aurell M, de Zeeuw D, Narins RG, Povar G. Angiotensin converting enzyme inhibitors and progressive renal insufficiency. Current experience and future directions. Ann Intern Med 1989 ; 111 : 503-16.
4. Taal MW, Brenner BM. ACE I vs angiotensin II receptor antagonists I prevention of renal injury in chronic rat models. J Hum Hypertens 1999 ; 13(Suppl 1) : S51-6.
5. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effects of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993 ; 329 : 1456-62.
6. Maschio G, Alberti D, Janin G, Locatelli F, Mann JF, Motolese M, Ponticelli C, Ritz E, Zucchelli P. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med 1996 ; 334 : 939-45.
7. Lafayette RA, Mayer G, Park SK, Meyer TW. Angiotensin II blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 1992 ; 90 : 766-71.
8. Remuzzi A, Perico N, Amuchastegui CS, Malanchini B, Mazerska M, Battaglia C, Bertani T, Remuzzi G. Short- and long-term effect of angiotensin II receptor blockade in rats with experimental diabetes. J Am Soc Nephrol ; 1993 : 40-9.
9. Kohzuki M, Yasujirna M, Kanazawa M, Yoshida K, Fu LP, Obara K, Saito T, Abe K. Antihypertensive and renalprotective effects of losartan in streptozotocin diabetic rats. J Hypertens 1995 ; 13 : 97-103.
10. Mizuno M, Sada T, Ikeda M, Fukuda N, Miyamoto M, Yanagisawa H, Koike H. Pharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonist. Eur J Pharmacol 1995 ; 285 : 181-8.
11. Furuta S, Kiyosawa K, Higuchi M, Kasahara H, Saito H, Shioya H, Oguchi H. Pharmacokinetics of temocapril, an ACE inhibitor with preferential biliary excretion, in patients with impaired liver function. Eur J Clin Pharmacol 1993 ; 44 : 383-5.
12. Yoshida K, Kohzuki M, Xu HL, Wu XM, Kamimoto M, Sato T. Effects of troglitazone and temocapril in spontaneously hypertensive rats with chronic renal failure. J Hypertens 2001 ; 19 : 503-10.
13. Kohzuki M, Kanazawa M, Liu PF, Kamimoto M, Yoshida K, Saito T, Yasujirna M, Sato T, Abe K. Kinin and angiotensin II receptor antagonists in rats with chronic renal failure : chronic effects on cardio- and renoprotection of angiotensin converting enzyme inhibitors. J Hypertens 1995 ; 13 : 1785-90.
14. van Damme B, Koudstaal J. Measuring glomerular diameters in tissue sections. Virchows Arch A Path Anat Histol 1976 ; 369 : 283-91.
15. Bennett WM, Walker RG, Kincaid-Smith P. Renal cortical interstitial volume in mesangial IgA nephropathy. Dissociation from creatinine clearance in serially biopsied patients. Lab Invest 1982 ; 47 : 330-5.
16. Ots M, Mackenzie HS, Troy JL, Rennke HG, Brenner BM. Effects of combination therapy with enalapril and losartan on the rate of progression of renal injury in rats with 5/6 renal mass ablation. J Am Soc Nephrol 1998 ; 9 : 224-30.
17. Ruilope LM, Aldigier JC, Ponticelli C, Oddou-Stock P, Botteri F, Mann JF. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. J Hypertens 2000 ; 18 : 89-95.
18. Russo D, Pisani A, Balletta MM, De Nicola L, Savino FA, Andreucci M, Minutolo R. Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy. Am J Kid Dis 1999 ; 33 : 851-6.
19. Textor SC, Gephardt GN, Bravo EL, Tarazi RC, Fouad FM, Tubbs R, McMahon JT. Membranous glomerulopathy associated with captopril therapy. Am J Med 1983 ; 74 : 705-12.
20. Brenner B. Nephron adaptation to renal injury or ablation. Am J Physiol 1985 ; 249 : F324-37.
21. Blantz RC, Pelayo JC. In vivo actions of angiotensin II on glomerular function. Fed Proc 1983 ; 42 : 3071-4.
22. Hsueh WA, Do YS, Anderson PW, Law RE. Angiotensin II in cell growth and matrix production. Adv Exp Med Biol 1995 ; 377 : 217-23.
23. Hajj-ali AF, Zimmerman BG. Kinin contribution to renal vasodilator effect of captopril in rabbit. Hypertension 1991 ; 17 : 504-9.
24. Mattson DL, Roman RJ. Role of kinins and angiotensin II in the renal hemodynamic response to captopril. Am J Physiol 1991 ; 260 : F670-9.
25. Kon V, Fogo A, Ichikawa I. Bradykinin causes selective efferent arteriolar dilation during angiotensin I converting enzyme inhibition. Kidney Int 1993 ; 44 : 545-50.
26. Nabokov A, Amann K, Gassmann P, Schwarz U, Orth SR, Ritz E. The renoprotective effect of angiotensin-converting enzyme inhibitors in experimental chronic renal failure is not dependent on enhanced kinin activity. Nephrol Dial Transplant 1998 ; 13 : 173-6.
27. Seyedi N, Xu XB, Nasjletti A, Hintze TH. Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation. Hypertension 1995 ; 26 : 164-70.
28. Liu YH, Yang XP, Sharov VG, Nass O, Sabbah HN, Peterson E, Carretero OA. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors. J Clin Invest 1997 ; 99 : 1926-35.
29. Brown SA, Walton CL, Crawford P, Bakris GL. Long-term effects of antihypertensive regimens on renal hemodynamics and proteinuria. Kidney Int 1993 ; 43 : 1210-8.
30. Bakris GL, Griffin KA, Picken MM, Bidani AK. Combined effects of an angiotensin converting enzyme inhibitor and a calcium antagonist on renal injury. J Hypertens 1997 ; 15 : 1181-5